Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ARAMIA: Candesartan in Dysglycemia and Abdominal Obesity
NCT00319202Phase 4Terminated
- Sponsor
- Fundación Cardiovascular de Colombia
- Start
- Jun 2006
- Primary completion
- Feb 2010
- Modality
- Prodrugs/Conditional Activator Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of candesartan in glucose intolerance, sponsored by Fundación Cardiovascular de Colombia. Started Jun 2006; status: terminated.
02
Drugs
candesartan
03
Conditions
glucose intolerance
Beyond the preview
Go deeper on NCT00319202.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00319202.